• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Liposomal formulations for treating lysosomal storage disorders
22 November 2022

Liposomal formulations for treating lysosomal storage disorders

We are pleased to present a literature review on “Liposomal formulations for treating lysosomal storage disorders”, published on Advanced Drug Delivery Reviews, with contribution of authors Josep Merlo, Alba Cordoba, and Santi Sala from Nanomol Technologies, in collaboration with researchers from CIBER-BBN and ICMAB-CSIC and led by our co-founder Prof. Nora Ventosa. 

Lysosomal storage disorders (LSD) are a group of rare diseases that are caused by lysosomal dysfunction, usually due to the lack of a single enzyme required for the metabolism of macromolecules, leading to a lysosomal accumulation of specific substrates, resulting in severe disease manifestations and premature death.  

There is currently no definitive cure for LSD and, despite the approval of certain therapies, their efficacy is limited. Therefore, a suitable nanocarrier could help improve the efficacy of some of these therapies. Liposomes show excellent properties as drug carriers, since they can entrap therapeutically active compounds offering protection, biocompatibility and selectivity.  

In this review, J. Tomsen-Melero et al. discuss the potential of liposomes for LSD treatment and a detailed analysis of promising liposomal formulations in the preclinical development stage is presented from various perspectives, including treatment strategy, manufacturing, characterization and future directions for the implementation of liposomal formulations for LSD.  The review also includes recent work using our DELOS technology to manufacture robust enzyme-loaded nanoliposomes for treatment of #Fabry disease.  

 

Want to learn more? Access the following link: https://www.sciencedirect.com/science/article/pii/S0169409X22004215?via%3Dihub 

Judit Tomsen-Melero, Josep Merlo-Mas, Aida Carreño, Santi Sala, Alba Córdoba, Jaume Veciana, Elisabet González-Mira, Nora Ventosa. Liposomal formulations for treating lysosomal storage disorders. Advanced Drug Delivery Reviews, Volume 190, 2022, 114531. https://doi.org/10.1016/j.addr.2022.114531. 

Related
news

Lídia Ballell, R&D Scientist of Nanomol Technologies, Poster Prize at the SCN2 II Annual Conference of Nanomedicine 20 November 2020

Lídia Ballell, R&D Scientist of Nanomol Technologies, Poster Prize at the SCN2 II Annual Conference of Nanomedicine

New nanocarrier for bio-imaging and drug-delivery applications 24 January 2020

New nanocarrier for bio-imaging and drug-delivery applications

Nanomol Technologies will attend the 7th edition of FarmaForum 27 October 2021

Nanomol Technologies will attend the 7th edition of FarmaForum

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki